New Products Watch
SEE OTHER BRANDS

The latest news on consumer products

Russia Deploys First Mass-Produced Oreshnik

(MENAFN) The initial batch of the Oreshnik hypersonic missile system has officially entered active duty within Russia's military forces, President Vladimir Putin declared on Friday during a military update concerning operations in Ukraine.

Russia previously tested the Oreshnik missile in real combat conditions in November, targeting a defense manufacturing site in Ukraine.

The weapon is considered potentially nuclear-capable.

However, Putin earlier emphasized that even in its standard configuration, it could deliver destruction on par with a low-yield atomic detonation.

Following a fruitful test run last year, Putin gave the green light for large-scale manufacturing of the new hypersonic arsenal.

The president confirmed on Friday that the first serially produced unit of the Oreshnik missile system has been finalized and handed over to Russian troops.

Additionally, Putin highlighted the possibility of exporting Oreshnik missiles to Belarus, expressing confidence that the matter would be settled before year’s end.

He mentioned that experts from both nations are actively working on identifying and preparing locations for future installation of the missile system.

MENAFN03082025000045017167ID1109878644

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions